These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6276025)

  • 1. Inhibition of plasminogen activator release from transformed chicken fibroblasts by a protease inhibitor.
    O'Donnell-Tormey J; Quigley JP
    Cell; 1981 Nov; 27(1 Pt 2):85-95. PubMed ID: 6276025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of plasminogen activator activity by the culture medium of Rous sarcoma virus-transformed cells.
    Mignatti P; Barlati S
    J Gen Virol; 1982 Dec; 63(2):365-73. PubMed ID: 6296283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts.
    Sullivan LM; Quigley JP
    Cell; 1986 Jun; 45(6):905-15. PubMed ID: 3011282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.
    O'Donnell-Tormey J; Quigley JP
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):344-8. PubMed ID: 6300832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease and metallo protease cascade systems involved in pericellular proteolysis.
    Quigley JP; Berkenpas MB; Aimes RT; Chen JM
    Cell Differ Dev; 1990 Dec; 32(3):263-75. PubMed ID: 1965954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
    Berkenpas MB; Quigley JP
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator and the membrane of transformed cells.
    Quigley JP; Goldfarb RH; Scheiner C; O'Donnell-Tormey J; Yeo TK
    Prog Clin Biol Res; 1980; 41():773-96. PubMed ID: 6256777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin A on plasminogen activator synthesis by chick embryo fibroblasts.
    Wilson EL; Reich E
    Haematol Blood Transfus; 1979; 23():319-23. PubMed ID: 232460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ts T mutant of Schmidt Ruppin strain of Rous sarcoma virus restricted at 39.5 degrees C for the morphological transformation and the tumorigenicity of chicken embryo fibroblasts.
    Poirier F; Lawrence D; Vigier P; Jullien P
    Int J Cancer; 1982 Jan; 29(1):69-76. PubMed ID: 6277805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells.
    Quigley JP
    J Cell Biol; 1976 Nov; 71(2):472-86. PubMed ID: 993259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator.
    Quigley JP
    Cell; 1979 May; 17(1):131-41. PubMed ID: 222474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between tumorigenicity and level of plasminogen activator in fibroblasts transformed by Rous sarcoma virus.
    Wolf BA; Goldberg AR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4967-71. PubMed ID: 217007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tumor promoters on sarc gene expression in normal and transformed chick embryo fibroblasts.
    Pietropaolo C; Laskin JD; Weinstein IB
    Cancer Res; 1981 Apr; 41(4):1565-71. PubMed ID: 6260344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.
    Quigley JP; Gold LI; Schwimmer R; Sullivan LM
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2776-80. PubMed ID: 3033662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of plasminogen activator by synchronized normal and Rous sarcoma virus-transformed chicken fibroblasts in culture.
    Sorić J; Brdar B
    Biochim Biophys Acta; 1982 Dec; 719(3):438-43. PubMed ID: 6295505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.
    Goldfarb RH; Quigley JP
    Cancer Res; 1978 Dec; 38(12):4601-9. PubMed ID: 214228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein and lipid lateral diffusion in normal and Rous sarcoma virus transformed chick embryo fibroblasts.
    Boullier JA; Peacock JS; Roess DA; Barisas BG
    Biochim Biophys Acta; 1992 Jun; 1107(1):193-9. PubMed ID: 1319742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rous-sarcoma-virus-transformed fibroblasts having low levels of plasminogen activator.
    Wolf BA; Goldberg AR
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3613-7. PubMed ID: 185621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protease activity in cultures of rous sarcoma virus-transformed cells: effect on the transformed phenotype.
    Weber MJ
    Cell; 1975 Jul; 5(3):253-61. PubMed ID: 167981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants.
    Fairbairn S; Gilbert R; Ojakian G; Schwimmer R; Quigley JP
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1790-8. PubMed ID: 2997235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.